Avalo Therapeutics Balance Sheet (2014-2026) | AVTX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Accumulated Depreciation (Quarter)
Assets
Current Assets
Cash & Equivalents (Quarter)	40.44M	71.51M	54.59M	0.10M	0.01M	16.94M	0.01M	16.69M	0.01M	0.00M	0.00M	110.18M	93.43M	81.86M	134.55M	125.05M	0.02M	0.09M	0.04M	0.15M
Receivables - Net (Quarter)	4.12M	1.44M	1.06M	0.94M	0.54M				0.04M
Receivables - Other (Quarter)	1.00M	2.48M	3.74M	1.00M	1.31M	1.31M	1.92M	0.86M	0.01M	1.54M	-0.50M	-0.10M	0.03M	1.00M	-0.60M
Receivables (Quarter)	5.12M	3.91M	4.80M	1.94M	1.85M	1.31M	1.92M		0.04M
Raw Materials (Quarter)
Finished Goods (Quarter)
Inventory (Quarter)	0.02M	0.02M	0.04M	0.03M	0.02M	0.02M	0.02M	0.02M	0.02M
Prepaid Assets (Quarter)	1.75M	1.41M	2.37M	2.68M	1.89M	1.12M	1.29M	1.63M	1.14M	0.94M	0.50M	0.10M	0.10M	0.90M	4.33M	1.83M	1.90M	2.14M	6.91M	6.68M
Current Assets (Quarter)	47.36M	77.01M	61.84M	43.66M	15.02M	19.45M	16.42M	19.25M	7.52M	12.66M	8.39M	111.21M	95.89M	86.15M	138.89M	126.94M	115.19M	113.85M	105.29M	88.83M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	1.43M	1.41M	2.69M	2.60M	2.57M	2.51M	2.41M	2.44M	2.18M	2.07M	1.97M	1.88M	1.78M	1.67M	1.21M	0.95M	0.69M	0.54M	0.46M	0.38M
Goodwill (Quarter)	14.41M	14.41M	14.41M	14.41M	14.41M	14.41M	14.41M	14.41M	14.41M	14.41M	10.50M	10.50M	10.50M	10.50M	10.50M	10.50M	10.50M	10.50M	10.50M	10.50M
Intangibles (Quarter)	0.73M	0.30M	0.04M
Goodwill & Intangibles (Quarter)	15.14M	14.71M	14.45M	14.41M	14.41M	14.41M	14.41M	14.41M	14.41M	14.41M	10.50M	10.50M	10.50M	10.50M	10.50M	10.50M	10.50M	10.50M	10.50M	10.50M
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)	0.15M	0.23M	0.23M	0.23M	0.23M	0.18M	0.13M	0.13M	0.13M	0.13M	0.13M	0.13M	0.13M	0.13M	0.13M	0.13M	0.21M	0.21M	0.21M	0.18M
Non-Current Assets (Quarter)	16.72M	18.35M	18.37M	18.24M	17.20M	17.10M	16.95M	16.98M	16.72M	16.61M	12.60M	12.52M	12.41M	12.31M	11.84M	11.58M	11.40M	11.25M	11.17M	11.06M
Assets (Quarter)	64.08M	95.36M	80.21M	61.90M	32.22M	36.55M	33.37M	36.23M	24.23M	29.27M	20.99M	123.73M	108.31M	98.45M	150.73M	138.52M	126.58M	125.10M	116.46M	99.89M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	3.96M	3.57M	3.37M	3.76M	2.16M	1.45M	2.88M	5.57M	0.75M	0.79M	0.45M	0.92M	0.65M	1.81M	0.28M	0.68M	2.37M	0.47M	0.14M	0.36M
Notes Payables (Quarter)	17.14M	32.48M		33.18M		2.56M	5.93M	9.30M	14.12M
Payables (Quarter)	21.11M	36.05M	3.37M	36.94M	2.16M	4.01M	8.81M	14.86M	14.87M	0.79M	0.45M	0.92M	0.65M	1.81M	0.28M	0.68M	2.37M	0.47M	0.14M	0.36M
Accumulated Expenses (Quarter)	17.61M	15.46M	16.52M	14.14M	13.23M	2.00M	2.00M	2.00M	0.61M	0.21M	2.00M	2.00M	2.00M	7.03M	0.33M	4.57M	6.52M	0.33M	2.00M	0.33M
Short term Debt (Quarter)															0.36M	0.36M	0.37M
Current Taxes (Quarter)
Current Deferred Revenue (Quarter)						0.40M	0.09M	0.11M
Total Current Liabilities (Quarter)	21.67M	19.04M	19.89M	17.89M	15.39M	18.15M	22.11M	23.25M	22.45M	6.00M	4.62M	215.70M	96.40M	60.67M	6.96M	5.62M	9.26M	7.97M	12.94M	11.60M
Non-Current Liabilities
Non-Current Debt (Quarter)			32.83M		18.71M	16.50M	13.49M	10.47M
Preferred Stock Liabilities (Quarter)												11.46M	11.46M	1.66M
Liabilities from Discontinued Operations (Quarter)	0.10M	0.01M
Operating Leases (Quarter)
Non-Current Deferred Tax Liability (Quarter)	0.12M	0.13M	0.11M	0.12M	0.13M	0.13M	0.14M	0.15M	0.16M	0.16M	0.15M	0.16M	0.17M	0.15M	1.43M	0.28M	0.29M	0.30M	0.43M	0.45M
Other Non-Current Liabilities (Quarter)	1.56M	1.40M	2.30M	2.36M	1.94M	1.79M	1.71M	1.63M	5.05M	4.95M	1.37M	1.28M	1.18M	11.81M	8.12M	7.74M	10.26M	0.12M	18.00M
Total Non-Current Liabilities (Quarter)	40.94M	53.65M	54.83M	53.20M	36.24M	36.78M	42.57M	40.87M	26.15M	9.62M	12.32M	223.53M	109.28M	63.91M	9.58M	8.17M	11.75M	33.44M	15.41M	31.57M
Total Liabilities (Quarter)	42.50M	55.05M	57.13M	55.56M	38.17M	38.58M	44.28M	42.50M	31.20M	14.57M	13.69M	224.81M	110.46M	75.72M	17.70M	15.91M	22.01M	33.55M	33.41M	31.57M
Shareholder's Equity
Total Debt (Quarter)			32.83M		18.71M	16.50M	13.49M	10.47M							0.36M	0.36M	0.37M
Common Equity (Quarter)	21.59M	40.31M	23.08M	6.34M	-5.95M	-2.03M	-10.91M	-6.27M	-6.97M	14.70M	7.30M	-112.54M	-13.61M	21.08M	133.03M	122.61M	104.57M	91.55M	83.05M	68.32M
Shareholder's Equity (Quarter)	21.59M	40.31M	23.08M	6.34M	-5.95M	-2.03M	-10.91M	-6.27M	-6.97M	14.70M	7.30M	-112.54M	-13.61M	21.08M	133.03M	122.61M	104.57M	91.55M	83.05M	68.32M
Liabilities and Shareholders Equity (Quarter)	64.08M	95.36M	80.21M	61.90M	32.22M	36.55M	33.37M	36.23M	24.23M	29.27M	20.99M	123.73M	108.31M	98.45M	150.73M	138.52M	126.58M	125.10M	116.46M	99.89M
Retained Earnings (Quarter)	-225.57M	-243.00M	-262.17M	-284.22M	-297.20M	-294.01M	-303.82M	-313.80M	-321.74M	-326.97M	-335.13M	-456.42M	-357.96M	-334.92M		-383.41M	-0.03M	-434.80M	-448.52M	-468.15M
Preferred Shares (Quarter)
Treasury Shares (Quarter)	0.08M	0.08M	0.01M	0.01M										0.63M	0.63M	0.42M	0.42M	0.42M	0.39M	0.19M
Shares Outstanding (Quarter)	8.00M	9.36M	0.04M	9.40M	9.41M	9.41M	0.04M	0.06M	0.06M	0.80M	0.80M	1.03M	1.03M	9.68M	10.47M	10.83M	10.84M	17.83M	18.51M	24.64M

Research Tools

Developers

Avalo Therapeutics Balance Sheet (2014-2026) | AVTX

Research Tools

Developers

Avalo Therapeutics Balance Sheet (2014-2026) | AVTX

Create an account

Sign In

Reset Password